Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wellgistics Health (WGRX) Depreciation & Amortization (CF) (2024 - 2025)

Wellgistics Health's Depreciation & Amortization (CF) history spans 2 years, with the latest figure at $39535.0 for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) fell 2.24% year-over-year to $39535.0, compared with a TTM value of $158804.0 through Dec 2025, up 134.86%, and an annual FY2025 reading of $158804.0, up 134.86% over the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $39535.0 at Wellgistics Health, roughly flat from $39731.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $40442.0 in Q4 2024, with the low at $27174.0 in Q3 2024.